Tilray Brands (TLRY) Accumulated Expenses (2017 - 2026)
Tilray Brands' (TLRY) quarterly Accumulated Expenses came in at $135.9 million in Q2 2026, up 31.62% YoY from $103.3 million in Q2 2025, and up 93.21% on a QoQ basis from $70.3 million in Q1 2026.
Tilray Brands (TLRY) Accumulated Expenses (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 9 years of Accumulated Expenses data on file, last reported at $135.9 million in Q2 2026.
- Quarterly Accumulated Expenses rose 31.62% year-over-year to $135.9 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $135.9 million (up 31.62% YoY) and the FY2026 annual result came in at $135.9 million, up 31.62% from the prior year.
- Accumulated Expenses rose to $135.9 million in Q2 2026, from $70.3 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $135.9 million in Q2 2026 to a low of $57.5 million in Q2 2022.
- A 5-year average of $85.3 million and a median of $82.5 million in 2025 frame the typical range for Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Accumulated Expenses soared 106.19% — and 2024, when it dropped 29.82%.
- Tracing TLRY's Accumulated Expenses over 5 years: stood at $63.5 million in 2022, then grew by 19.37% to $75.9 million in 2023, then grew by 15.85% to $87.9 million in 2024, then decreased by 6.09% to $82.5 million in 2025, then soared by 64.7% to $135.9 million in 2026.
- The last three Accumulated Expenses figures came in at $135.9 million (Q2 2026), $70.3 million (Q1 2026), and $82.5 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - |
| 10 | Tilray Brands | 513.87 Mn | 279.24 Mn | 90.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 135.91 Mn |
| Feb 28, 2026 | 70.34 Mn |
| Nov 30, 2025 | 82.52 Mn |
| Aug 31, 2025 | 91.99 Mn |
| May 31, 2025 | 103.26 Mn |
| Feb 28, 2025 | 88.87 Mn |
| Nov 30, 2024 | 87.87 Mn |
| Aug 31, 2024 | 90.90 Mn |
| May 31, 2024 | 92.42 Mn |
| Feb 29, 2024 | 70.74 Mn |
| Nov 30, 2023 | 75.85 Mn |
| Aug 31, 2023 | 129.52 Mn |
| May 31, 2023 | 78.01 Mn |
| Feb 28, 2023 | 68.32 Mn |
| Nov 30, 2022 | 63.55 Mn |
| Aug 31, 2022 | 62.82 Mn |
| May 31, 2022 | 57.50 Mn |
| Mar 31, 2020 | 47.03 Mn |
| Dec 31, 2019 | 50.83 Mn |
| Sep 30, 2019 | 71.39 Mn |